Federman & Sherwood Investigates Kootenai Health for Data Breach
Federman & Sherwood Investigates Kootenai Health for Data Breach
The law firm of Federman & Sherwood has initiated an investigation into Kootenai Health and its subsidiaries, Kootenai Clinic, Kootenai Outpatient Surgery, and Kootenai Outpatient Imaging with respect to their recent data breach. On March 2, 2024, Kootenai became aware of an unauthorized cybersecurity incident on their network. Kootenai immediately launched an investigation into the incident. The investigation determined that an unauthorized party accessed certain individuals’ sensitive information on Kootenai’s network on or around February 22, 2024. Kootenai began sending notices to affected individuals on August 12, 2024.
The type of information potentially exposed includes:
- full name
- Social Security number
- date of birth
- driver’s license or other government-issued ID
- health insurance
- medical information
- as well as other sensitive information
If you wish to discuss this action, obtain further information, and/or participate in this litigation, please contact Tiffany Peintner either by email at info@federmanlaw.com or visit our firm’s website www.federmanlaw.com.
Tiffany Peintner
FEDERMAN & SHERWOOD
(405) 235-1560
View source version on businesswire.com: https://www.businesswire.com/news/home/20240814580633/en/
-
What’s the Difference Between the CPI and PCE Indexes?
-
Micron Earnings: Great Guidance but Stock Now Looks Fairly Valued
-
August PCE Report Forecasts Show More Good News on Inflation
-
AI Stocks May Be Down, but Don’t Count Them Out
-
4 Stocks to Buy as the Fed Cuts Interest Rates
-
Markets Brief: The Uncertain Path to Neutral Interest Rates
-
What’s Happening in the Markets This Week
-
Where Top Stock Fund Managers Are Looking Next After the Fed Rate Cut
-
Our Top Pick for Investing in US Renewable Energy
-
Undervalued by 25% and Yielding 5%, This Stock Is a Buy
-
Can AI Predict Future Stock Returns?
-
The Best Energy Stocks to Buy Now
-
10 Undervalued Wide-Moat Stocks
-
Obesity Drugs: Can New Firms Take Market Share From Eli Lilly and Novo Nordisk?
-
New 4-Star Stocks
-
Intel Fair Value Left Unchanged Despite Qualcomm Takeover Talk